Skip to main content
. 2017 Nov 15;7:15645. doi: 10.1038/s41598-017-15154-6

Figure 3.

Figure 3

SR141716A ameliorates metabolic dysfunction in diet-induced obesity. Experiments Diet-Induced Obesity (DIO)were set up as described in Fig. 1 legend. (a) Glucose tolerance test (GTT) and (b) Insulin tolerance test (ITT) of mice fed LFD + Vehicle (n = 10), HFD + Vehicle (n = 10), HFD + SR (n = 9) and Pair-fed to SR141716A (PFSR) (n = 10). Each animal received by oral gavage 1.5 g/kg body mass of glucose (25% D-glucose). Blood glucose levels were determined after 15, 30, 60 and 120 minutes. Insulin-tolerance tests were carried out on un-fasted animals by i.p injection of 1.5 U/kg body mass of insulin. Blood glucose levels were detected after 15, 30, 60 and 120 minutes. Generalized Linear Mixed Model (GLMM) was performed to calculate p values for the repeated measures in SPSS. Mean Area Under the Curve (AUC) from triplicate experiments measured between 0–120 minutes after glucose (GTT) and insulin (ITT) load. AUC was assessed with Trapezoidal rule in R software. Data with different superscript letters are significantly different. GTT (P < 0.01), ITT (P < 0.05).